# Boundless Bio, Inc.: Form 8-K, filed Aug 28, 2026

- Company: [Boundless Bio, Inc.](/companies/bold.md) (CIK 1782303)
- Form: 8-K
- Filed: 2026-08-28
- Accepted by EDGAR: Aug 28, 2026, 17:25 ET
- Period: 2026-08-28
- Accession: 0001193125-26-374787
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782303/000119312526374787/d111273d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782303/000119312526374787/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782303/000119312526374787/d111273d8k.htm

Filed Aug 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-374787. Last ingested by Listed: Nov 11, 2026, 03:14 ET. No prices; not investment advice.
